06 August, 2025
Updates and announcements
COMMUNICATION OF CONCESSION FOR POR FESR 2021-2027
PROCESS OPTIMIZATION IN THE BIOMEDICAL FIELD.
THE OBJECTIVE OF THE PROJECT IS TO SUPPORT THE COMPANY IN IN THE INNOVATION OF ITS PRODUCTION PROCESSES, ACCOMPANYING THE COMPANY FROM THE DESIGN PHASE UP TO THE FINAL PRODUCTION OF PRODUCTS, BY MEANS OF STRATEGIC INVESTMENTS IN MATERIAL GOODS AND SPECIALIST CONSULTING. IN PARTICULAR, TECHNOLOGICALLY ADVANCED TOOLS HAVE BEEN ACQUIRED TO GUARANTEE HIGH QUALITY STANDARDS AND RAPIDITY IN DEVELOPMENT, IN ADDITION TO THE IMPLEMENTATION OF CUSTOMIZED INFORMATION SOLUTIONS FOR THE AGILE DEVELOPMENT OF NEW DIAGNOSTIC TESTING, IN COMPLIANCE WITH THE STRICT REQUIREMENTS OF ISO 13485.
ALLOWABLE EXPENDITURE. 191.635,00 EURO
CONTRIBUTE PR FESR FVG 76.654,00 EURO
OF WHICH UE 30.661,60 EURO